kentucky semaglutide gastric intestinal obstruction lawsuit stomach paralysis law firm attorney semaglutide diarrhea in louisiana kentucky semaglutide dallas semaglutide gastric intestinal obstruction

The Food and Drug Administration (FDA) approved orforglipron for weight loss in April, based on results from the first part of the randomized, double-blinded placebo-controlled clinical trial

CM-101 is currently being evaluated in a PSC phase 2 study

Cold Spring Harb Perspect Biol 7:a020412 Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long covid: major findings, mechanisms and recommendations

Physicians including gastroenterologists have been blunt that these products do not contain GLP-1 or a GLP-1 agonist and are unlikely to reproduce the drug's effect

Here we explore why semaglutide causes constipation and what to do about it, with insights from experienced Registered Dietitian, Sarah Nash, RD , and physician, Gia Eapen, MD

The principal task at this time is to determine the risk of hepatocellular injury, and this involves two considerations: the time elapsed from the toxic ingestion, and the plasma level of acetaminophen